logo
Why AST SpaceMobile Stock Skyrocketed 102.6% Last Month, but Has Slipped in July

Why AST SpaceMobile Stock Skyrocketed 102.6% Last Month, but Has Slipped in July

Globe and Mail08-07-2025
Key Points
AST SpaceMobile stock roared to a new record high last month thanks to multiple bullish catalyts.
Positive momentum for the broader market, business-specific news, and analyst coverage contributed to the stock's rally.
AST SpaceMobile stock has seen a mild pullback early in this month's trading.
10 stocks we like better than AST SpaceMobile ›
AST SpaceMobile (NASDAQ: ASTS) stock recorded huge gains across June's trading. The space technology company's share price surged 102.6% in a month that saw the S&P 500 (SNPINDEX: ^GSPC) rise 5% and the Nasdaq Composite (NASDAQINDEX: ^IXIC) jump 6.6%.
Excitement surrounding defense technology plays and bullish momentum for the broader market helped AST stock close out the period with huge gains. New partnership announcements, investment speculation, and analyst coverage also helped power the rally.
AST SpaceMobile stock had an incredible rally last month
June was a month of massive bullish momentum for space tech stocks, and investors piled into AST stock on some promising growth indicators for the company. Along those lines, the stock got a significant boost on June 4 after Scotiabank highlighted the possibility that Jeff Bezos and his Blue Origin space exploration company could invest in AST.
On June 16, B. Riley published new coverage maintaining a buy rating on AST. The investment firm also raised its one-year price target on the stock from $36 per share to $44 per share and pointed to the space-tech specialist's growing spectrum resources as a catalyst that could help support further valuation growth.
AST and Vodafone then announced on June 18 that they had entered into a new partnership to bring connectivity offerings to untapped markets in India. The two companies' collaboration on the SpaceMobile Satellite System could bring space-based cellular broadband services to a huge section of new customers, and it looks like foundations are being laid for the business to scale rapidly. Along with moves to clarify and expand its spectrum access last month, the expansion of the partnership with Vodafone strengthened AST's long-term performance outlook.
Why has AST stock pulled back in July?
On the heels of last month's explosive gains, AST stock has seen a modest pullback in July's trading. The company's share price is down roughly 3.5% in the month as of this writing, but it's still up 264% over the last year.
There actually haven't been any negative, business-specific developments for the company this month, but investors are showing some signs of valuation concerns after a massive valuation run-up.
On the other hand, Roth Capital published new coverage on AST on Monday -- reiterating a buy rating and raising its one-year price target on the stock from $42 per share to $51 per share. Roth's analysts see recent wins for T-Mobile 's Starlink-enabled services are a positive indicator because it views AST's service and pricing offerings as superior.
With signs of strong competitive positioning, some analysts and investors are betting the stock will soon go on to reach new highs. AST remains a high-risk, reward play, but the company is executing at a high level and has some huge growth opportunities ahead.
Should you invest $1,000 in AST SpaceMobile right now?
Before you buy stock in AST SpaceMobile, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AST SpaceMobile wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $695,481!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $969,935!*
Now, it's worth noting Stock Advisor 's total average return is1,053% — a market-crushing outperformance compared to179%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 7, 2025
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Globe and Mail

time7 minutes ago

  • Globe and Mail

RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025. Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) RP-A501 was less effective than defendants had led investors to believe; (2) to increase its effectiveness, Rocket Pharmaceuticals amended RP-A501's clinical trial protocol by introducing a novel immunomodulatory agent; (3) the foregoing increased the risk that patients would suffer from a Serious Adverse Event ('SAE'); (4) accordingly, RP-A501's safety, as well as its clinical, regulatory, and commercial prospects, were overstated; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Rocket Pharmaceuticals, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 11, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.

Opendoor Regains Nasdaq Compliance, Cancels Stockholder Meeting
Opendoor Regains Nasdaq Compliance, Cancels Stockholder Meeting

Globe and Mail

time7 minutes ago

  • Globe and Mail

Opendoor Regains Nasdaq Compliance, Cancels Stockholder Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Opendoor Technologies ( (OPEN)) just unveiled an update. On July 31, 2025, Opendoor Technologies Inc. announced it regained compliance with Nasdaq's minimum bid price requirement, as its stock maintained a closing bid price of at least $1.00 for 12 consecutive business days. Consequently, the company canceled a Special Meeting of Stockholders scheduled for August 27, 2025, which was intended to discuss a reverse stock split, as the Board deemed it unnecessary following the regained compliance. The most recent analyst rating on (OPEN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Opendoor Technologies stock, see the OPEN Stock Forecast page. Spark's Take on OPEN Stock According to Spark, TipRanks' AI Analyst, OPEN is a Neutral. Opendoor Technologies faces significant financial challenges with declining revenues and negative earnings, leading to a low valuation score. However, technical analysis shows some positive momentum, and the company's strategic initiatives highlighted in the earnings call provide a cautiously optimistic outlook. The overall score reflects these mixed factors, with financial performance being the most significant constraint. To see Spark's full report on OPEN stock, click here. Opendoor Technologies Inc. is a leading e-commerce platform focused on residential real estate transactions, providing a simplified and certain way for people across the U.S. to sell and buy homes. The company operates nationwide and aims to innovate the future of real estate. Average Trading Volume: 175,164,562 Technical Sentiment Signal: Hold Current Market Cap: $1.34B For an in-depth examination of OPEN stock, go to TipRanks' Overview page.

Celtics minority owner reaches deal to buy Connecticut Sun for record $325M US, move team to Boston: reports
Celtics minority owner reaches deal to buy Connecticut Sun for record $325M US, move team to Boston: reports

CBC

time7 minutes ago

  • CBC

Celtics minority owner reaches deal to buy Connecticut Sun for record $325M US, move team to Boston: reports

A group led by Celtics minority owner Steve Pagliuca has reached a deal to buy the Connecticut Sun for a record $325 million US and move the team to Boston, according to a person familiar with the sale. The franchise wouldn't play in Boston until the 2027 season. Pagliuca also would contribute $100 million for a new practice facility in Boston for the team, the person said. The person spoke to The Associated Press on condition of anonymity on Saturday because the deal hasn't been publicly announced. The sale is pending approval of the league and its Board of Governors. "Relocation decisions are made by the WNBA Board of Governors and not by individual teams," the league said in a statement. The Sun have played one regular season game at TD Garden each of the last two years, including one against Caitlin Clark and the Indiana Fever in July. The league has announced five expansion teams that will begin play over the next five seasons with Portland (2026), Toronto (2026), Cleveland (2028), Detroit (2029) and Philadelphia (2030) joining the WNBA. Each paid a then-record $250 million expansion fee. Nine other cities bid for expansion teams, including Houston, which the league singled out as getting a team in the future when it announced Cleveland, Detroit and Philadelphia in June. Boston did not. "No groups from Boston applied for a team at that time and those other cities remain under consideration based on the extensive work they did as part of the expansion process and currently have priority over Boston. Celtics' prospective ownership team has also reached out to the league office and asked that Boston receive strong consideration for a WNBA franchise at the appropriate time." The Boston Globe first reported the sale. The Sun are owned by the Mohegan Tribe, which runs the casino where the team has played since 2003. The Tribe bought the franchise for $10 million and relocated it from Orlando that year. The Connecticut franchise was the first in the league to be run by a non-NBA owner and also became the first to turn a profit. The team announced in May that it was searching for a potential buyer for the franchise and had hired investment bank Allen & Company to conduct the probe. The WNBA has experienced rapid growth the last few seasons and ownership groups have been investing more into their teams, including player experiences. That has come in the way of practice facilities. The Sun are one of the few teams in the league that haven't announced any plans for a new training facility. Connecticut practices either at the arena in the casino or a local community centre. Despite the lack of facilities, the Sun have been one of the most successful teams in the league, making the post-season in 16 seasons, including a run of six straight semifinal appearances. But the team was hit hard this off-season with the entire starting five from last season leaving either via free agency or trade. Connecticut is currently in last place in the WNBA at 5-21. The team sent out a letter to season ticket holders last week saying they'd still be playing at the casino next year. The last team to be sold in the WNBA was in 2021 when real estate investor Larry Gottesdiener led a group that bought the Atlanta Dream for under $10 million. A year earlier, Mark Davis paid roughly $2 million for the Las Vegas Aces.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store